Abstract
Stroke,is the third leading cause of death and disability in the Western world.Stroke refers to set of ischemic conditions resulting from the occlusion or hemorrhage of blood vessels supplying the brain.Loss of blood flow to the brain results in neuronal injury due to both oxygen and nutrient deprivation and the activation of injurious signal cascades.Ultimately cerebral ischemia results in death and dysfunction of brain cells,and neurological deficits that reflect the location and size of the compromised brain area.Injury due to ischemic stroke occurs by a highly choreographed series of complex spatial and temporal events that evolve over hours to days.These events involve complex interactions between fundamental cell injury mechanisms including excitotoxicity and ionic imbalance, oxidative and nitrosative stress,apoptotic-like cell death and inflammatory responses.Genetically engineered mice have been valuable tools to probe putative mechanisms of neuronal death and uncover potential strategies that might render neurons resistant to ischemic injury.Findings from experimental stroke studies in genetically engineered animals are discussed.
Keywords: Ischemic Injury, apoptotic, hemorrhage, nitrosative
Current Molecular Medicine
Title: What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Volume: 4 Issue: 2
Author(s): Dong Liang, Ted M. Dawson and Valina L. Dawson
Affiliation:
Keywords: Ischemic Injury, apoptotic, hemorrhage, nitrosative
Abstract: Stroke,is the third leading cause of death and disability in the Western world.Stroke refers to set of ischemic conditions resulting from the occlusion or hemorrhage of blood vessels supplying the brain.Loss of blood flow to the brain results in neuronal injury due to both oxygen and nutrient deprivation and the activation of injurious signal cascades.Ultimately cerebral ischemia results in death and dysfunction of brain cells,and neurological deficits that reflect the location and size of the compromised brain area.Injury due to ischemic stroke occurs by a highly choreographed series of complex spatial and temporal events that evolve over hours to days.These events involve complex interactions between fundamental cell injury mechanisms including excitotoxicity and ionic imbalance, oxidative and nitrosative stress,apoptotic-like cell death and inflammatory responses.Genetically engineered mice have been valuable tools to probe putative mechanisms of neuronal death and uncover potential strategies that might render neurons resistant to ischemic injury.Findings from experimental stroke studies in genetically engineered animals are discussed.
Export Options
About this article
Cite this article as:
Liang Dong, Dawson M. Ted and Dawson L. Valina, What have Genetically Engineered Mice Taught Us About Ischemic Injury?, Current Molecular Medicine 2004; 4 (2) . https://dx.doi.org/10.2174/1566524043479194
DOI https://dx.doi.org/10.2174/1566524043479194 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
Call for Papers in Thematic Issues
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders
Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Safety Considerations of the Use of Second Generation Antipsychotics in the Treatment of Major Depression: Extrapyramidal and Metabolic Side Effects
Current Drug Safety Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Comparison of Oxidative Stress and Inflammation Induced by Different Intravenous Iron Sucrose Similar Preparations in a Rat Model
Inflammation & Allergy - Drug Targets (Discontinued) Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Does Daily Dialysis Improve Hypertension in Chronic Haemodialysis Patients?
Current Hypertension Reviews Angiotensins and Their Receptors in Cardiac and Vascular Injury
Current Hypertension Reviews GHB, GBL and 1,4-BD Addiction
Current Pharmaceutical Design Medications Affecting Functional Status in Older Persons
Current Pharmaceutical Design Agonistic and Antagonistic Bivalent Ligands for Serotonin and Dopamine Receptors Including their Transporters
Current Topics in Medicinal Chemistry Corticosteroids in Sepsis: Pathophysiological Rationale and the Selection of Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunosuppressive Therapy for Myelodysplastic Syndromes
Current Pharmaceutical Design Psoriatic Arthritis and its Novel Therapeutics
Current Rheumatology Reviews Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences
New Emirates Medical Journal Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?
Current Pharmaceutical Design N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
Current Alzheimer Research Complement Activation-Related Pseudoallergy Caused by Amphiphilic Drug Carriers: The Role of Lipoproteins
Current Drug Delivery Bosentan in Pediatric Patients with Pulmonary Arterial Hypertension
Current Vascular Pharmacology Clinical and Molecular Perspectives of Monogenic Hypertension
Current Hypertension Reviews